BMS And J&J CAR-Ts Flagged For Early Deaths Ahead of Back-To-Back FDA Advisory Panels

 
• By Sarah Karlin-Smith
  
Illustration of T cells attacking cancer cells
FDA advisors will vote on earlier indications for two CAR-T products in multiple myeloma 15 March • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers